GH Research PLC (GHRS): Price and Financial Metrics

GH Research PLC (GHRS): $10.95

1.34 (+13.94%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

C

Add GHRS to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#74 of 332

in industry

GHRS Price/Volume Stats

Current price $10.95 52-week high $14.99
Prev. close $9.61 52-week low $5.05
Day low $9.50 Volume 95,000
Day high $11.09 Avg. volume 79,758
50-day MA $7.87 Dividend yield N/A
200-day MA $10.16 Market Cap 569.71M

GHRS Stock Price Chart Interactive Chart >


GH Research PLC (GHRS) Company Bio


GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH001, an inhalable 5-MeO-DMT product candidate that is being investigated in the Phase 2 part of an ongoing Phase 1/2 clinical trial in patients with TRD. The company also develops GH002, an injectable 5-MeO-DMT product candidate that is in preclinical development trials with a focus on psychiatric and neurological disorders. GH Research PLC was founded in 2018 and is based in Dublin, Ireland.


GHRS Latest News Stream


Event/Time News Detail
Loading, please wait...

GHRS Latest Social Stream


Loading social stream, please wait...

View Full GHRS Social Stream

GHRS Price Returns

1-mo 31.93%
3-mo -4.62%
6-mo -20.07%
1-year 58.47%
3-year -55.58%
5-year N/A
YTD 88.79%
2023 -40.33%
2022 -58.34%
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!